Amerise Biosciences
BSE: 531681
₹ 0.82▲ 0.03 (+3.8%)28 Oct, 03:17 pm IST
- Market cap
- ₹ 5 Cr.
- P/E
- 333.6x
- P/B
- 0.99x
- 52-week range
- 0.5 – 1.03
- ROE
- 0%
- ROCE
- 0.4%
- Dividend yield
- 0%
- Debt / equity
- 0
- Sector
- Industrial Products
- Industry
- Plastic Products - Industrial
- Listed on
- BSE
About
Amerise Biosciences Limited is an India-based company. The Company is not engaged in any activity. The Company did not generate any revenue.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Plastic Products - Industrial: 78 companies →Amerise Biosciences against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)333.6 against a typical 20.5: pricier than most peers (1st = cheapest).73rd of 76
- Sales growth−100% against a typical +14.5% from a year earlier.61st of 66
- Share price, 3 months−17.2% against a typical −8.5%.46th of 61
- Size₹ 5.4 Cr. market value against a typical ₹ 104.4 Cr. (1st = largest).63rd of 68
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | −0 | −0 | 0 | −0 | −0 | −0 | 0 | −0 | −0 | 0 | 0 | −0 |
| OPM % | — | — | 50% | — | — | — | 57.9% | −16.7% | −57.1% | 25% | 75% | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −0 | −0 | 0 | −0 | −0 | −0 | 0 | −0 | −0 | 0 | 0 | −0 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | −0 | −0 | 0 | −0 | −0 | −0 | 0 | −0 | −0 | 0 | 0 | −0 |
| EPS in Rs | −0.01 | −0.01 | 0 | −0.01 | 0 | 0 | 0.02 | 0 | −0.01 | 0 | 0.01 | −0.01 |
Growth and returns
Compounded yearly rates over each period.
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 196%
- TTM
- −24%
Compounded Profit Growth
- 10 Years
- 10%
- 5 Years
- 16%
- 3 Years
- 29%
- TTM
- −200%
Stock Price CAGR
- 10 Years
- −6%
- 5 Years
- −10%
- 3 Years
- 9%
- TTM
- —
Return on Equity
- 10 Years
- −2%
- 5 Years
- 1%
- 3 Years
- −1%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
P/E 333.6xEPS (12 months) ₹ 0.00Median P/E 169.4x
P/E (times)EPS (₹)
Peers
Listed companies in the same business.
| Amerise Biosciences | ₹ 0.82 | ₹ 5 Cr. | 333.6x | 1x | 0% | — |
| REC | ₹ 293.65 | ₹ 77,325 Cr. | 5.7x | 1.1x | 20% | 27.4% |
| Altius Telecom Infrastructure Trust | ₹ 170.00 | ₹ 0 Cr. | 46.7x | 4.5x | 8.3% | 4.6% |
| National Highways Infra Trust | ₹ 168.00 | ₹ 35,928 Cr. | 47.7x | 1.5x | 3% | 16% |
| IndiGrid Infrastructure Trust | ₹ 164.83 | ₹ 15,701 Cr. | 39.1x | 2.8x | 7% | 8.4% |
| Indus Infra Trust | ₹ 124.00 | ₹ 7,576 Cr. | 15x | 1.2x | — | 56.5% |
Management
- Dineshkumar Tribhovanbhai Rathod
- Chief Financial Officer, Whole-time Director
- Soni Pandiya
- Compliance Officer, Company Secretary
- Albert Hines
- Wholetime Director
Prices are delayed and for information only. Nothing on this page is investment advice.